The First Approved Therapy in Infants and Young Children With Eosinophilic Esophagitis - Now the Big Question: Where Will Dupilumab Fit Into Real-World Practice? - PubMed (original) (raw)
. 2025 May;168(5):1026-1027.
doi: 10.1053/j.gastro.2024.10.007. Epub 2024 Oct 10.
Affiliations
- PMID: 39393541
- DOI: 10.1053/j.gastro.2024.10.007
The First Approved Therapy in Infants and Young Children With Eosinophilic Esophagitis - Now the Big Question: Where Will Dupilumab Fit Into Real-World Practice?
Eric E Low et al. Gastroenterology. 2025 May.
No abstract available
LinkOut - more resources
Full Text Sources